The ZNF148 ‐ ZEB1 ‐ AS1 ‐ IGF2BP2 ‐ NOD2 Axis Drives Microglial Antipneumococcal Immunity in Bacterial Meningitis
Glia · 2026
DOI: 10.1002/glia.70125 ↗Kurz gefasst
Fachartikel in der Zeitschrift Glia, 2026. Verfasst von Xiufu Hu und 6 weiteren Autor:innen. Beteiligte Einrichtung: Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, China. Hauptthemen laut MEDLINE: Microglia, Nod2 Signaling Adaptor Protein, Transcription Factors, RNA-Binding Proteins. Die Arbeit nennt 76 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY-NC-ND 4.0). Gefördert von: National Natural Science Foundation of China, Key Research and Development Program of Shandong Province, Key Technology Research and Development Program of Shandong Province.
Abstract (Originalsprache)
Streptococcus pneumoniae (Spn) meningitis remains a lethal central nervous system (CNS) infection with limited therapies. This study identifies the lncRNA ZEB1‐AS1 as a central coordinator of microglial immunity against Spn through a multi‐tiered regulatory cascade. Transcriptomic analysis revealed Spn‐induced ZEB1‐AS1 upregulation in human microglia, driven by ZNF148, which directly binds its promoter. Functional interrogation demonstrated that ZEB1‐AS1 knockdown impairs bacterial clearance and pro‐inflammatory cytokine production (IL‐1β, IL‐6, TNF‐α, p < 0.01), while its overexpression amplifies these responses. Crucially, ZEB1‐AS1 recruits the m6A reader IGF2BP2 to stabilize NOD2 mRNA in cytoplasmic complexes, extending transcript stability. This molecular scaffolding enables NOD2‐dependent antimicrobial functions, as evidenced by rescue experiments in which IGF2BP2 overexpression reversed ZEB1‐AS1 deficiency phenotypes. In vivo, microglial manipulation of the murine homolog Zeb1‐os1 regulated cerebral Spn burdens, NOD2 expression, and infection‐induced cognitive outcomes in both directions. The tripartite ZEB1‐AS1/IGF2BP2/NOD2 interaction was validated by RNA pulldown and co‐immunoprecipitation, establishing a linear pathway from ZNF148‐mediated transcriptional activation to IGF2BP2‐dependent mRNA stabilization. Collectively, this ZNF148 to ZEB1‐AS1 to IGF2BP2 to NOD2 axis bridges the gap between transcriptional and post‐transcriptional immune regulation, proposing IGF2BP2's RNA‐binding domain as a therapeutic target against drug‐resistant Spn meningitis.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Pediatrics, Qilu Hospital of Shandong University, Jinan, Shandong, China.
- Shandong Public Health Clinical Center, Jinan, Shandong, China.
ORCID-Profile: Aihua Cao
Förderung
- National Natural Science Foundation of China
- Key Research and Development Program of Shandong Province
- Key Technology Research and Development Program of Shandong Province
Zitieren
APA
Hu, X., Jiang, F., Liu, X., Li, L., Hu, R., Dong, M., & Cao, A. (2026). The ZNF148 ‐ ZEB1 ‐ AS1 ‐ IGF2BP2 ‐ NOD2 Axis Drives Microglial Antipneumococcal Immunity in Bacterial Meningitis. Glia. https://doi.org/10.1002/glia.70125
Vancouver
Hu X, Jiang F, Liu X, Li L, Hu R, Dong M, et al. The ZNF148 ‐ ZEB1 ‐ AS1 ‐ IGF2BP2 ‐ NOD2 Axis Drives Microglial Antipneumococcal Immunity in Bacterial Meningitis. Glia. 2026. doi:10.1002/glia.70125
BibTeX
@article{Hu2026,
author = {Hu, Xiufu and Jiang, Fang and Liu, Xinjie and Li, Ling and Hu, Ruimei and Dong, Meng and Cao, Aihua},
title = {The ZNF148 ‐ ZEB1 ‐ AS1 ‐ IGF2BP2 ‐ NOD2 Axis Drives Microglial Antipneumococcal Immunity in Bacterial Meningitis},
journal = {Glia},
year = {2026},
doi = {10.1002/glia.70125}
}
EUVIMED